Stay updated on Nivolumab in IDH-Mutant Gliomas Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in IDH-Mutant Gliomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in IDH-Mutant Gliomas Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page’s footer now identifies the ClinicalTrials.gov site revision as v3.8.1 instead of v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-18T02:57:09.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for NCT03718767 is displayed with study details, eligibility, outcomes, investigators, record dates, and supporting documents, replacing the 403 error view.
    Difference
    60%
    Check dated 2026-11-11T01:56:53.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The site revision displayed in the footer changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-04T00:25:57.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    An NIH notice about its website transition and updated terminology appears above the page, while the clinical trial record still displays a 403 Forbidden error. The site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:30:03.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The footer revision number was updated from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-07T00:36:52.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Removed the 403 Forbidden error screen HTML and related elements, addressing a core access issue that previously blocked viewing the study details. This change suggests the page can render the study details normally without displaying an error screen.
    Difference
    0.5%
    Check dated 2026-09-30T00:46:11.000Z thumbnail image

Stay in the know with updates to Nivolumab in IDH-Mutant Gliomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in IDH-Mutant Gliomas Clinical Trial page.